XENE Xenon Pharmaceuticals Inc. - Common Shares

NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗
$54,95
Kurs · Mai 20, 2026
Fundamentaldaten per Mai 7, 2026

XENE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$54.95
Marktkapitalisierung
$3.59B
P/E (TTM)
-10.3
EPS (TTM)
$-4.36
Umsatz (TTM)
$8M
Dividendenrendite
ROE
-56.9%
Verschuldungsgrad
52W-Spanne
$28 – $64

XENE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $8M
9-point trend, +316.0%
2016-12-31 2025-12-31
EPS $-4.36
9-point trend, -194.6%
2016-12-31 2025-12-31
Freier Cashflow $-280M
10-point trend, -1310.4%
2016-12-31 2025-12-31
Margen -4612.1%

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
XENE
Peer-Median
P/E (TTM)
5-point trend, +41.8%
-10.3
7.0
P/S (TTM) (K/V (TTM))
5-point trend, +785.1%
478.1
22.0
P/B (K/B)
5-point trend, +110.2%
6.2
6.1
Price / FCF (Kurs / FCF)
5-point trend, +43.2%
-12.8

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
XENE
Peer-Median
Operating Margin (Betriebsgewinnmarge)
5-point trend, -693.3%
-4974.3%
Net Profit Margin (Nettogewinnmarge)
5-point trend, -657.2%
-4612.1%
-202.2%
ROA
5-point trend, -133.2%
-48.3%
-32.5%
ROE
5-point trend, -188.2%
-56.9%
-42.4%
ROIC
5-point trend, -347.9%
-64.3%

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
XENE
Peer-Median
Current Ratio (Liquiditätsgrad)
5-point trend, -65.6%
13.4
8.7
Quick Ratio
5-point trend, -66.1%
13.1

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
XENE
Peer-Median
Revenue CAGR 3Y (Umsatz CAGR 3J)
5-point trend, -59.3%
-7.4%
Revenue CAGR 5Y (Umsatz CAGR 5J)
5-point trend, -59.3%
-25.3%

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
XENE
Peer-Median
EPS (Diluted) (EPS (Verwässert))
5-point trend, -146.3%
$-4.36

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
XENE
Peer-Median

XENE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 26 Analysten
  • Starker Kauf 11 42,3%
  • Kauf 14 53,8%
  • Halten 1 3,8%
  • Verkauf 0 0,0%
  • Starker Verkauf 0 0,0%

12-Monats-Kursziel

19 Analysten · 2026-05-17
Median-Ziel $80.00 +45,6%
Mittelwert-Ziel $79.19 +44,1%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
0.00%
Zeitraum EPS Actual EPS est. Überraschung
31. März 2026 $-1.17 $-1.21 0.04%
31. Dezember 2025 $-1.31 $-1.22 -0.09%
30. September 2025 $-1.15 $-1.18 0.03%
30. Juni 2025 $-1.07 $-1.01 -0.06%
31. März 2025 $-0.83 $-0.93 0.10%

Vergleich mit Konkurrenten Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
XENE $3.59B -10.3 -4612.1% -56.9%
AUPH $2.11B 7.7 20.4% 101.5% 62.7%
ABUS $926M -28.3 128.2% -237.9% -42.0%
ZYME $1.97B -24.4 38.9% -76.6% -26.9%
ACOG $141M -5.5 -202.2% -43.8%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 16
Jährliche Gewinn- und Verlustrechnung-Daten für XENE
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue 11-point trend, -73.6% $8M $0 $0 $9M $18M $32M $7M · $311.0K $2M $16M $28M
R&D Expense 12-point trend, +2457.3% $301M $210M $168M $106M $75M $51M $39M $24M $26M $20M $15M $12M
SG&A Expense 12-point trend, +1348.9% $80M $69M $47M $33M $22M $13M $11M $8M $7M $7M $10M $5M
Operating Expenses 12-point trend, +2104.4% $381M $279M $214M $139M $97M $63M $50M $38M $33M $27M $25M $17M
Operating Income 12-point trend, -3459.2% $-373M $-279M $-214M $-129M $-79M $-31M $-43M $-38M $-33M $-25M $-9M $11M
Interest Expense 3-point trend, -65.3% · · · · · $484.0K $1M $1M · · · ·
Interest Income 12-point trend, +4623.2% $27M $42M $28M $9M $466.0K $2M $2M $1M $477.0K $504.0K $542.0K $568.0K
Other Non-op 6-point trend, +1176.7% $28M $41M $31M $4M $105.0K $2M · · · · · ·
Pretax Income 8-point trend, -899.1% $-345M $-238M $-183M $-125M $-79M $-29M $-42M $-35M · · · ·
Income Tax 9-point trend, +1016000.00 $1M $-4M $-292.0K $118.0K $-6.0K $-257.0K $-23.0K $-24.0K · · · $0
Net Income 12-point trend, -2757.2% $-346M $-234M $-182M $-125M $-79M $-29M $-42M $-34M $-31M $-23M $-16M $13M
EPS (Basic) 11-point trend, -206.1% $-4.36 $-3.01 $-2.73 $-2.06 $-1.77 $-0.81 · $-1.63 $-1.71 $-1.48 $-1.10 $4.11
EPS (Diluted) 11-point trend, -232.9% $-4.36 $-3.01 $-2.73 $-2.06 $-1.77 $-0.81 · $-1.63 $-1.72 $-1.48 $-1.10 $3.28
Shares (Basic) 11-point trend, +2403.6% 79,253,751 77,894,643 66,889,005 60,542,142 43,627,452 34,542,213 · 19,425,711 17,985,061 15,493,474 14,281,837 3,165,572
Shares (Diluted) 11-point trend, +1899.4% 79,253,751 77,894,643 66,889,005 60,542,142 43,627,452 34,542,213 · 19,425,711 18,001,759 15,493,474 14,281,837 3,963,797
EBITDA 12-point trend, -3249.9% $-373M $-279M $-214M $-129M $-79M $-31M $-43M $-38M $-33M $-25M $-9M $12M
Bilanz 23
Jährliche Bilanz-Daten für XENE
Kennzahl Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +176.5% $199M $143M $149M $57M $176M $45M $25M $68M $20M $17M $59M $72M
Short-term Investments 11-point trend, +2810.7% $350M $484M $489M $535M $376M $132M $117M $52M $23M $47M · $12M
Receivables 11-point trend, +583.3% · $1M $874.0K $986.0K $3M $2M $813.0K $151.0K $438.0K $200.0K $315.0K $215.0K
Prepaid Expense 12-point trend, +1414.9% $10M $7M $6M $7M $4M $3M $3M $2M $716.0K $1M $2M $686.0K
Current Assets 12-point trend, +560.0% $561M $635M $645M $600M $559M $182M $145M $121M $45M $66M $61M $85M
PP&E (Net) 12-point trend, +252.2% $9M $10M $10M $6M $4M $4M $2M $991.0K $1M $1M $2M $2M
Accum. Depreciation 12-point trend, +14.1% $15M $13M $11M $9M $13M $15M $15M $16M $16M $15M $15M $14M
Total Assets 12-point trend, +624.3% $633M $798M $965M $754M $572M $189M $148M $122M $46M $67M $64M $87M
Accounts Payable 12-point trend, +1411.3% $40M $34M $26M $22M $14M $11M $9M $4M $3M $4M $3M $3M
Accrued Liabilities $36M · · · · · · · · · · ·
Current Liabilities 12-point trend, +192.5% $42M $36M $27M $23M $14M $15M $43M $4M $4M $4M $3M $14M
Capital Leases 7-point trend, +763.0% $6M $8M $10M $10M $8M $3M $743.0K · · · · ·
Other Non-current Liabilities 2-point trend, +3199000.00 $3M $0 · · · · · · · · · ·
Total Liabilities 12-point trend, +251.1% $51M $43M $37M $33M $22M $18M $56M $19M $10M $4M $3M $15M
Long-term Debt 2-point trend, +128.4% · · · · · · $16M · $7M · · ·
Total Debt 3-point trend, +128.4% · · · · · · $16M $15M $7M · · ·
Common Stock 12-point trend, +986.3% $1.60B $1.46B $1.44B $1.07B $783M $398M $294M $266M $174M $173M $149M $147M
Paid-in Capital · · · · · · · · · · · $30M
Retained Earnings 12-point trend, -1100.6% $-1.25B $-899M $-665M $-483M $-357M $-278M $-250M $-208M $-173M $-143M $-120M $-104M
AOCI 12-point trend, +133.8% $335.0K $-2M $-77.0K $-3M $-990.0K $-990.0K $-990.0K $-990.0K $-990.0K $-990.0K $-990.0K $-990.0K
Stockholders' Equity 12-point trend, +699.4% $582M $755M $928M $721M $550M $171M $92M $103M $36M $64M $61M $73M
Liabilities + Equity 12-point trend, +624.3% $633M $798M $965M $754M $572M $189M $148M $122M $46M $67M $64M $87M
Shares Outstanding 12-point trend, +464.2% 80,010,790 76,416,086 75,370,977 62,587,701 51,634,752 35,012,125 28,139,228 25,750,721 17,998,420 17,930,590 14,385,336 14,181,333
Cashflow 14
Jährliche Cashflow-Daten für XENE
Kennzahl Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, +244.6% $3M $3M $2M $1M $906.0K $644.0K $429.0K $586.0K $649.0K $864.0K $1M $738.0K
Stock-based Comp 12-point trend, +6966.7% $54M $51M $32M $20M $10M $6M $3M $3M $2M $2M $4M $760.0K
Deferred Tax 8-point trend, -2945.7% $-3M $-9M $-292.0K $-44.0K $58.0K $-285.0K $-133.0K $-105.0K · · · ·
Other Non-cash · · · · · · · · · · · $-14M
Operating Cash Flow 12-point trend, -105031.6% $-279M $-181M $-151M $-101M $-70M $-48M $-5M $-35M $-29M $-20M $-18M $266.0K
CapEx 12-point trend, -47.7% $799.0K $3M $6M $3M $2M $3M $1M $507.0K $315.0K $279.0K $551.0K $2M
Investing Cash Flow 9-point trend, +797.3% $218M $165M $-111M $-293M $-247M $-17M $-66M $-29M $24M · · ·
Stock Issued 6-point trend, +140.3% · · · · · $102M $27M $103M · $24M $278.0K $43M
Net Stock Activity 6-point trend, +140.2% · · · · · $102M $27M $103M · $24M $278.0K $43M
Financing Cash Flow 9-point trend, +1556.5% $117M $12M $354M $278M $448M $86M $28M $112M $7M · · ·
Net Change in Cash 12-point trend, +65.7% $56M $-6M $91M $-118M $131M $20M $-43M $47M $3M $-42M $-13M $34M
Taxes Paid $8M · · · · · · · · · · ·
Free Cash Flow 12-point trend, -22062.9% $-280M $-184M $-151M $-101M $-72M $-51M $-6M $-35M $-29M $-20M $-19M $-1M
Levered FCF 2-point trend, -601.4% · · · · · $-51M $-7M · · · · ·
Rentabilität 7
Jährliche Rentabilität-Daten für XENE
Kennzahl Trend 202520242023202220212020201920182017201620152014
Operating Margin 9-point trend, -12805.7% -4974.3% · · -1368.9% -428.5% -97.3% -627.0% · -10474.3% -1376.4% -60.1% 39.1%
Net Margin 9-point trend, -10150.4% -4612.1% · · -1329.0% -427.9% -89.6% -609.1% · -9872.7% -1275.5% -101.1% 45.9%
Pretax Margin 5-point trend, -654.6% -4598.6% · · -1327.7% -427.9% -90.5% -609.4% · · · · ·
EBITDA Margin 9-point trend, -12014.4% -4974.3% · · -1368.9% -428.5% -97.3% -627.0% · -10474.3% -1376.4% -60.1% 41.8%
ROA 12-point trend, -363.4% -48.3% -26.6% -21.2% -18.9% -20.7% -17.1% -30.8% -40.9% -54.0% -35.0% -20.8% 18.4%
ROE 12-point trend, +87.8% -56.9% -30.2% -23.3% -17.0% -19.8% -16.3% -50.0% -32.2% -61.5% -36.8% -23.5% -465.5%
ROIC 7-point trend, -61.6% -64.3% -36.4% -23.0% -17.9% -14.4% -18.1% -39.8% · · · · ·
Liquidität & Solvenz 5
Jährliche Liquidität & Solvenz-Daten für XENE
Kennzahl Trend 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +125.6% 13.4 17.8 23.6 26.4 39.0 12.3 3.3 29.5 11.0 18.7 21.9 5.9
Quick Ratio 12-point trend, +122.7% 13.1 17.7 23.4 26.1 38.7 12.1 3.3 29.0 10.8 18.3 21.2 5.9
Debt / Equity 3-point trend, -10.8% · · · · · · 0.2 0.1 0.2 · · ·
LT Debt / Equity 3-point trend, -30.3% · · · · · · 0.1 0.1 0.2 · · ·
Interest Coverage 3-point trend, -137.1% · · · · · -64.7 -29.9 -27.3 · · · ·
Effizienz 2
Jährliche Effizienz-Daten für XENE
Kennzahl Trend 202520242023202220212020201920182017201620152014
Asset Turnover 9-point trend, -97.4% 0.0 · · 0.0 0.0 0.2 0.1 · 0.0 0.0 0.2 0.4
Receivables Turnover 8-point trend, -94.2% · · · 5.0 8.0 24.4 14.2 · 1.0 7.0 58.8 86.6
Pro Aktie 5
Jährliche Pro Aktie-Daten für XENE
Kennzahl Trend 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +41.7% $7.27 $9.88 $12.31 $11.53 $10.65 $4.89 $3.27 $4.01 $2.00 $3.56 $4.24 $5.13
Revenue / Share 6-point trend, -98.7% $0.09 · · $0.16 · · · · $0.02 $0.12 $1.09 $7.16
Cash Flow / Share 9-point trend, -5348.6% $-3.52 $-2.33 $-2.17 $-1.63 · · · $-1.79 $-1.60 $-1.26 $-1.27 $0.07
Cash / Share 12-point trend, -51.0% $2.49 $1.87 $1.97 $0.91 $3.40 $1.29 $0.88 $2.63 $1.14 $0.95 $4.08 $5.08
EPS (TTM) 12-point trend, -232.9% $-4.36 $-3.01 $-2.73 $-2.06 $-1.77 $-0.81 $-1.87 $-1.63 $-1.72 $-1.48 $-1.10 $3.28
Wachstumsraten 3
Jährliche Wachstumsraten-Daten für XENE
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue YoY 2-point trend, -14.4% · · · -48.8% -42.7% · · · · · · ·
Revenue CAGR 3Y -7.4% · · · · · · · · · · ·
Revenue CAGR 5Y -25.3% · · · · · · · · · · ·
Bewertung (TTM) 14
Jährliche Bewertung (TTM)-Daten für XENE
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, -73.6% $8M $0 $0 $9M $18M $32M $7M $311.0K $311.0K $2M $16M $28M
Net Income TTM 12-point trend, -2757.2% $-346M $-234M $-182M $-125M $-79M $-29M $-42M $-34M $-31M $-23M $-16M $13M
Market Cap 12-point trend, +1180.4% $3.59B $3.00B $3.47B $2.47B $1.61B $538M $369M $162M $51M $138M $116M $280M
Enterprise Value 3-point trend, +1638.5% · · · · · · $243M $58M $14M · · ·
P/E 12-point trend, -270.7% -10.3 -13.0 -16.9 -19.1 -17.6 -19.0 -7.0 -3.9 -1.6 -5.2 -7.3 6.0
P/S 10-point trend, +4743.2% 478.1 · · 261.6 87.5 16.7 54.0 522.5 163.5 76.6 7.4 9.9
P/B 12-point trend, +60.2% 6.2 4.0 3.7 3.4 2.9 3.1 4.0 1.6 1.4 2.2 1.9 3.8
P / Tangible Book 6-point trend, +96.2% 6.2 4.0 3.7 3.4 2.9 3.1 · · · · · ·
P / Cash Flow 12-point trend, -101.2% -12.8 -16.5 -23.9 -25.1 -23.2 -11.2 -79.6 -4.7 -1.8 -7.1 -6.4 1052.9
P / FCF 12-point trend, +94.2% -12.8 -16.2 -23.0 -24.4 -22.5 -10.6 -62.8 -4.6 -1.8 -7.0 -6.2 -221.8
EV / EBITDA 3-point trend, -1222.7% · · · · · · -5.7 -1.5 -0.4 · · ·
EV / FCF 3-point trend, -8497.6% · · · · · · -41.4 -1.7 -0.5 · · ·
EV / Revenue 3-point trend, -20.8% · · · · · · 35.6 187.1 45.0 · · ·
Earnings Yield 12-point trend, -158.6% -9.7% -7.7% -5.9% -5.2% -5.7% -5.3% -14.3% -25.8% -60.9% -19.2% -13.7% 16.6%

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung
2025-12-312024-12-312023-12-312022-12-312021-12-31
Umsatz $8M$0$0$9M$18M
Betriebsgewinnmarge % -4974.3%-1368.9%-428.5%
Nettoergebnis $-346M$-234M$-182M$-125M$-79M
Verwässerte EPS $-4.36$-3.01$-2.73$-2.06$-1.77
Bilanz
2025-12-312024-12-312023-12-312022-12-312021-12-31
Liquiditätsgrad 13.417.823.626.439.0
Quick Ratio 13.117.723.426.138.7
Cashflow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Freier Cashflow $-280M$-184M$-151M$-101M$-72M

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.